Literature DB >> 31906402

Kinetic, Thermodynamic, and Crystallographic Studies of 2-Triazolylthioacetamides as Verona Integron-Encoded Metallo-β-Lactamase 2 (VIM-2) Inhibitor.

Yang Xiang1,2, Yue-Juan Zhang1, Ying Ge1, Yajun Zhou3, Cheng Chen1, Weixiao Yuan Wahlgren4, Xiangshi Tan3, Xi Chen1, Ke-Wu Yang1.   

Abstract

Inhibition of β-lactamases presents a promising strategy to restore the β-lactams antibacterial activity to resistant bacteria. In this work, we found that aromatic carboxyl substituted 2-triazolylthioacetamides 1a-j inhibited VIM-2, exhibiting an IC50 value in the range of 20.6-58.6 μM. The structure-activity relationship study revealed that replacing the aliphatic carboxylic acid with aromatic carboxyl improved the inhibitory activity of 2-triazolylthioacetamides against VIM-2. 1a-j (16 mg/mL) restored the antibacterial activity of cefazolin against E. coli cell expressing VIM-2, resulting in a 4-8-fold reduction in MICs. The isothermal titration calorimetry (ITC) characterization suggested that the primary binding 2-triazolylthioacetamide (1b, 1c, or 1h) to VIM-2 was a combination of entropy and enthalpy contributions. Further, the crystal structure of VIM-2 in complex with 1b was obtained by co-crystallization with a hanging-drop vapour-diffusion method. The crystal structure analysis revealed that 1b bound to two Zn(II) ions of the enzyme active sites, formed H-bound with Asn233 and structure water molecule, and interacted with the hydrophobic pocket of enzyme activity center utilizing hydrophobic moieties; especially for the phenyl of aromatic carboxyl which formed π-π stacking with active residue His263. These studies confirmed that aromatic carboxyl substituted 2-triazolylthioacetamides are the potent VIM-2 inhibitors scaffold and provided help to further optimize 2-triazolylthioacetamides as VIM-2 even or broad-spectrum MβLs inhibitors.

Entities:  

Keywords:  2-triazolylthioacetamides; antibiotic resistance; crystallographic study; metallo-β-lactamase VIM-2 inhibitor; thermodynamics

Mesh:

Substances:

Year:  2020        PMID: 31906402      PMCID: PMC7022493          DOI: 10.3390/biom10010072

Source DB:  PubMed          Journal:  Biomolecules        ISSN: 2218-273X


  33 in total

1.  Discovery of Novel Inhibitor Scaffolds against the Metallo-β-lactamase VIM-2 by Surface Plasmon Resonance (SPR) Based Fragment Screening.

Authors:  Tony Christopeit; Trine Josefine O Carlsen; Ronny Helland; Hanna-Kirsti S Leiros
Journal:  J Med Chem       Date:  2015-10-27       Impact factor: 7.446

Review 2.  Bacterial resistance to beta-lactam antibiotics: compelling opportunism, compelling opportunity.

Authors:  Jed F Fisher; Samy O Meroueh; Shahriar Mobashery
Journal:  Chem Rev       Date:  2005-02       Impact factor: 60.622

3.  Kinetics of avibactam inhibition against Class A, C, and D β-lactamases.

Authors:  David E Ehmann; Haris Jahic; Philip L Ross; Rong-Fang Gu; Jun Hu; Thomas F Durand-Réville; Sushmita Lahiri; Jason Thresher; Stephania Livchak; Ning Gao; Tiffany Palmer; Grant K Walkup; Stewart L Fisher
Journal:  J Biol Chem       Date:  2013-08-02       Impact factor: 5.157

4.  Design, synthesis, and in vitro and biological evaluation of potent amino acid-derived thiol inhibitors of the metallo-β-lactamase IMP-1.

Authors:  Omid Khalili Arjomandi; Waleed M Hussein; Peter Vella; Yusralina Yusof; Hanna E Sidjabat; Gerhard Schenk; Ross P McGeary
Journal:  Eur J Med Chem       Date:  2016-03-09       Impact factor: 6.514

5.  Azolylthioacetamides as a potent scaffold for the development of metallo-β-lactamase inhibitors.

Authors:  Yang Xiang; Ya-Nan Chang; Ying Ge; Joon S Kang; Yi-Lin Zhang; Xiao-Long Liu; Peter Oelschlaeger; Ke-Wu Yang
Journal:  Bioorg Med Chem Lett       Date:  2017-10-20       Impact factor: 2.823

6.  A protein structure-guided covalent scaffold selectively targets the B1 and B2 subclass metallo-β-lactamases.

Authors:  Cheng Chen; Yang Xiang; Ke-Wu Yang; Yuejuan Zhang; Wen-Ming Wang; Jian-Peng Su; Ying Ge; Ya Liu
Journal:  Chem Commun (Camb)       Date:  2018-05-08       Impact factor: 6.222

7.  Triazolylthioacetamide: A Valid Scaffold for the Development of New Delhi Metallo-β-Lactmase-1 (NDM-1) Inhibitors.

Authors:  Le Zhai; Yi-Lin Zhang; Joon S Kang; Peter Oelschlaeger; Lin Xiao; Sha-Sha Nie; Ke-Wu Yang
Journal:  ACS Med Chem Lett       Date:  2016-02-16       Impact factor: 4.345

8.  The three-dimensional structure of VIM-2, a Zn-beta-lactamase from Pseudomonas aeruginosa in its reduced and oxidised form.

Authors:  I Garcia-Saez; J-D Docquier; G M Rossolini; O Dideberg
Journal:  J Mol Biol       Date:  2007-11-13       Impact factor: 5.469

9.  Biochemical, mechanistic, and spectroscopic characterization of metallo-β-lactamase VIM-2.

Authors:  Mahesh Aitha; Amy R Marts; Alex Bergstrom; Abraham Jon Møller; Lindsay Moritz; Lucien Turner; Jay C Nix; Robert A Bonomo; Richard C Page; David L Tierney; Michael W Crowder
Journal:  Biochemistry       Date:  2014-11-13       Impact factor: 3.162

10.  Structural basis of metallo-β-lactamase, serine-β-lactamase and penicillin-binding protein inhibition by cyclic boronates.

Authors:  Jürgen Brem; Ricky Cain; Samuel Cahill; Michael A McDonough; Ian J Clifton; Juan-Carlos Jiménez-Castellanos; Matthew B Avison; James Spencer; Colin W G Fishwick; Christopher J Schofield
Journal:  Nat Commun       Date:  2016-08-08       Impact factor: 14.919

View more
  1 in total

1.  Investigation of the Role of Aromatic Residues in the Antimicrobial Peptide BuCATHL4B.

Authors:  Matthew R Necelis; Luis E Santiago-Ortiz; Gregory A Caputo
Journal:  Protein Pept Lett       Date:  2021       Impact factor: 1.890

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.